ALDH1A2 and lip and oral cavity carcinoma: In this study, we found that NNK and arecoline treatment could recruit DNMT3B to ADHFE1 and ALDH1A2 promoter region, subsequently repressed the expression of ADHFE1 and ALDH1A2 in oral cancer.